Champions Oncology Inc reports results for the quarter ended in January - Earnings Summary

Champions Oncology

15/03/2023 21:58

* Champions Oncology Inc  CSBR.OQ  reported a quarterly
adjusted
loss of 18 cents​​ per share for the quarter ended in January.
The mean expectation of three analysts for the quarter was for a
loss of 4 cents per share.
    * Revenue fell 3.2% to $12.77 million from a year ago;
analysts
expected $13.13 million. 
    * Champions Oncology Inc's reported EPS for the quarter was
a loss
of 18 cents​.
    * The mean earnings estimate of analysts had fallen by
about 250%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Champions Oncology Inc shares had fallen by 4.4% this
quarter.
    * The company reported a quarterly loss of $2.44 million.
    * Wall Street's median 12-month price target for Champions
Oncology Inc is $12.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
March 15 at 09:58 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jan. 31 2023      -0.03          -0.18          Missed
 Oct. 31 2022      -0.01          0.00           Beat
 Jul. 31 2022      0.01           -0.02          Missed
 Apr. 30 2022      0.03           -0.03          Missed